NuCana (NASDAQ:NCNA) Trading Down 6.5% – Time to Sell?

NuCana plc (NASDAQ:NCNA)’s stock price was down 6.5% during trading on Thursday . The stock traded as low as $1.14 and last traded at $1.15. Approximately 118,431 shares were traded during mid-day trading, an increase of 6% from the average daily volume of 111,346 shares. The stock had previously closed at $1.23.

NuCana Trading Down 6.5 %

The firm’s 50-day moving average price is $1.33 and its two-hundred day moving average price is $2.64. The stock has a market cap of $3.04 million, a PE ratio of -0.11 and a beta of 0.97.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in NuCana stock. Glass Jacobson Investment Advisors llc bought a new stake in shares of NuCana plc (NASDAQ:NCNA) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 15,000 shares of the company’s stock, valued at approximately $38,000. Glass Jacobson Investment Advisors llc owned about 0.57% of NuCana as of its most recent SEC filing. Hedge funds and other institutional investors own 44.00% of the company’s stock.

NuCana Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. It applies its ProTide technology to transform prescribed chemotherapy agents and nucleoside analogs into medicines. The company, through its technology, is developing ProTides medicines to overcome the limitations of nucleoside analogs and generate much higher concentrations of anti-cancer metabolites in cancer cells.